1-7 of 7
Louis Boon
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages

Aleksandar Murgaski, Máté Kiss, Helena Van Damme, Daliya Kancheva, Isaure Vanmeerbeek, Jiri Keirsse, Eva Hadadi, Jan Brughmans, Sana M. Arnouk, Ahmed E.I. Hamouda, Ayla Debraekeleer, Victor Bosteels, Yvon Elkrim, Louis Boon, Sabine Hoves, Niels Vandamme, Sofie Deschoemaeker, Sophie Janssens, Abhishek D. Garg, Greetje Vande Velde, Martina Schmittnaegel, Carola H. Ries, Damya Laoui
Journal: Cancer Research
Cancer Res (2022) 82 (20): 3785–3801.
https://doi.org/10.1158/0008-5472.CAN-22-0094
Published: 17 October 2022
View article titled, Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages
Open the PDF for Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages in another window
Includes: Supplementary data
Journal Articles

Abstract A08: TGFβb inhibition improves oncolytic herpes viroimmunotherapy in murine models of rhabdomyosarcoma

Brian Hutzen, Chun-Yu Chen, Pin-Yi Wang, Les Sprague, Swain M. Hayley, Julia Love, Joe Conner, Louis Boon, Timothy P. Cripe
Journal: Cancer Research
Cancer Res (2018) 78 (19_Supplement): A08.
https://doi.org/10.1158/1538-7445.PEDCA17-A08
Published: 01 October 2018
View article titled, Abstract A08: TGFβb inhibition improves oncolytic herpes viroimmunotherapy in murine models of rhabdomyosarcoma
Journal Articles

Sialic Acid Blockade Suppresses Tumor Growth by Enhancing T-cell–Mediated Tumor Immunity

Christian Büll, Thomas J. Boltje, Natasja Balneger, Sarah M. Weischer, Melissa Wassink, Jasper J. van Gemst, Victor R. Bloemendal, Louis Boon, Johan van der Vlag, Torben Heise, Martijn H. den Brok, Gosse J. Adema
Journal: Cancer Research
Cancer Res (2018) 78 (13): 3574–3588.
https://doi.org/10.1158/0008-5472.CAN-17-3376
Published: 01 July 2018
View article titled, Sialic Acid Blockade Suppresses Tumor Growth by Enhancing T-cell–Mediated Tumor Immunity
Open the PDF for Sialic Acid Blockade Suppresses Tumor Growth by Enhancing T-cell–Mediated Tumor Immunity in another window
Includes: Supplementary data
Journal Articles

Antitumor Immunity Triggered by Melphalan Is Potentiated by Melanoma Cell Surface–Associated Calreticulin

Aleksandra M. Dudek-Perić, Gabriela B. Ferreira, Angelika Muchowicz, Jasper Wouters, Nicole Prada, Shaun Martin, Santeri Kiviluoto, Magdalena Winiarska, Louis Boon, Chantal Mathieu, Joost van den Oord, Marguerite Stas, Marie-Lise Gougeon, Jakub Golab, Abhishek D. Garg, Patrizia Agostinis
Journal: Cancer Research
Cancer Res (2015) 75 (8): 1603–1614.
https://doi.org/10.1158/0008-5472.CAN-14-2089
Published: 14 April 2015
View article titled, Antitumor Immunity Triggered by Melphalan Is Potentiated by Melanoma Cell Surface–Associated Calreticulin
Open the PDF for Antitumor Immunity Triggered by Melphalan Is Potentiated by Melanoma Cell Surface–Associated Calreticulin in another window
Includes: Supplementary data
Journal Articles

Immunotherapy with PI3K Inhibitor and Toll-Like Receptor Agonist Induces IFN-γ+IL-17+ Polyfunctional T Cells That Mediate Rejection of Murine Tumors

Neil A. Marshall, Karen C. Galvin, Anna-Maria B. Corcoran, Louis Boon, Rowan Higgs, Kingston H.G. Mills
Journal: Cancer Research
Cancer Res (2012) 72 (3): 581–591.
https://doi.org/10.1158/0008-5472.CAN-11-0307
Published: 31 January 2012
View article titled, Immunotherapy with PI3K Inhibitor and Toll-Like Receptor Agonist Induces IFN-γ<sup>+</sup>IL-17<sup>+</sup> Polyfunctional T Cells That Mediate Rejection of Murine Tumors
Open the PDF for Immunotherapy with PI3K Inhibitor and Toll-Like Receptor Agonist Induces IFN-γ<sup>+</sup>IL-17<sup>+</sup> Polyfunctional T Cells That Mediate Rejection of Murine Tumors in another window
Includes: Supplementary data
Journal Articles

Immune Adjuvant Efficacy of CpG Oligonucleotide in Cancer Treatment Is Founded Specifically upon TLR9 Function in Plasmacytoid Dendritic Cells

Stefan Nierkens, Martijn H. den Brok, Zacharias Garcia, Susan Togher, Jori Wagenaars, Melissa Wassink, Louis Boon, Theo J. Ruers, Carl G. Figdor, Stephen P. Schoenberger, Gosse J. Adema, Edith M. Janssen
Journal: Cancer Research
Cancer Res (2011) 71 (20): 6428–6437.
https://doi.org/10.1158/0008-5472.CAN-11-2154
Published: 12 October 2011
View article titled, Immune Adjuvant Efficacy of CpG Oligonucleotide in Cancer Treatment Is Founded Specifically upon TLR9 Function in Plasmacytoid Dendritic Cells
Open the PDF for Immune Adjuvant Efficacy of CpG Oligonucleotide in Cancer Treatment Is Founded Specifically upon TLR9 Function in Plasmacytoid Dendritic Cells in another window
Journal Articles

Potent Antitumor Immunity Generated by a CD40-Targeted Adenoviral Vaccine

Basav N. Hangalapura, Dinja Oosterhoff, Jan de Groot, Louis Boon, Thomas Tüting, Alfons J. van den Eertwegh, Winald R. Gerritsen, Victor W. van Beusechem, Alexander Pereboev, David T. Curiel, Rik J. Scheper, Tanja D. de Gruijl
Journal: Cancer Research
Cancer Res (2011) 71 (17): 5827–5837.
https://doi.org/10.1158/0008-5472.CAN-11-0804
Published: 30 August 2011
View article titled, Potent Antitumor Immunity Generated by a CD40-Targeted Adenoviral Vaccine
Open the PDF for Potent Antitumor Immunity Generated by a CD40-Targeted Adenoviral Vaccine in another window
Includes: Supplementary data